Chairman, former Executive Chairman · Rallybio Corp (RLYB)

Martin Mackay

A named executive officer of Rallybio in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,102,862

Salary $551,200Stock awards $0

FY2023: $1,765,084

2nd of 4 named executive officers at Rallybio by FY2024 total.

4 named officers on file for Rallybio, FY2024

Martin Mackay’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Rallybio’s whole pay program stands against its peers

  • Rallybio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RLYB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 7, 2025 (DEF 14A).

Free

Get Martin Mackay’s full pay file as a PDF — free

More than this page: up to 10 years of Martin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Martin Mackay compensation by year

Rallybio Summary Compensation Table · all 2 fiscal years held
In US dollars, as Rallybio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$530,000$551,200
Bonus$0$0
Stock awards$0$0
Option awards$1,054,934$314,626
Non-equity incentive$166,950$223,236
Pension and deferred compensation$0$0
All other$13,200$13,800
Total$1,765,084$1,102,862

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Rallybio Corp DEF 14A filed April 7, 2025, accession 0001739410-25-000045, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Rallybio Corp filed document, accession 0001739410-25-000045. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2025.

$1.8M
$1.1M
FY23
FY24
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,680$5,453—
Option171,000—$1.86
Option23,334—$13.00
Option18,084—$15.04
Option115,917—$6.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Rallybio Corp's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Rallybio’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Stephen UdenChief Executive Officer and President$1,127,666
Martin Mackay · this pageChairman, former Executive Chairman$1,102,862
Steven RyderChief Medical Officer$911,061
Jonathan LieberChief Financial Officer and Treasurer$839,216

The full Rallybio compensation record

free company brief

This page is one person within Rallybio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Rallybio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Martin Mackay's compensation dossier · One-time report. No refunds.